Baltimore, MD · Founded 2014 · Privately Held (backing)
Developer of in vitro diagnostic tests designed to aid diagnosis and screening for bacterial and fungal lung infections. Pearl Diagnostics is based in Baltimore, MD and was founded in 2014. Its last reported valuation was $15 million in Jun 2022. It has raised $4.5 million across 2 recorded rounds; the latest was an $11.2 million early-stage round in Mar 2026.
Last reported valuation
$15.0M
Oct 2026
Priced at
—
Total raised
$4.5M
Last round
Early Stage VC
Mar 2026
Team — not yet on record
No current team members for Pearl Diagnostics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Pearl Diagnostics with a free account
·The complete investor list: 11 names
·Watch Pearl Diagnostics: the Monday email on marks, rounds and moves
